PHOTOTHERAPORT

#PHOTOTHERAPORT combine locally light-emitting implants and light-controlled drugs to modulate neuronal activity locally and on-demand. Funded by @EU_Commission

[PHOTOTHERAPORT @PHOTOTHERAPORT]

💡 Light to treat neurological diseases & pain? It's near!
Luisa Camerin at @IBEC explains how the project 🔬#PHOTOTHERAPORT uses photo-switchable drugs 💊activated by light for precise treatment.
Learn more: https://t.co/XWt4UBiqKg
#Neurology #PainManagement #LightTherapy

[PHOTOTHERAPORT @PHOTOTHERAPORT]

From toxin to light-controlled tool: researchers in the #PHOTOTHERAPORT project have engineered “Azoveratridine”, a photoswitchable derivative of the neurotoxin veratridine that can be reversibly activated with light.

➡️ A new step forward for photopharmacology.

[IBEC @IBECBarcelona]

IBEC engineers a light-controlled version of the alkaloid neurotoxin veratridine by chemically installing an azobenzene photoswitch, enabling reversible photoactivation in neurons and cardiac tissue.

➡️ https://t.co/kHePtrT5h1

[PHOTOTHERAPORT @PHOTOTHERAPORT]

🌟 Light is more than illumination, it can become a therapeutic tool. 

Through photobiomodulation and photopharmacology, we are exploring safer, more precise, and personalized medical solutions.

[PHOTOTHERAPORT @PHOTOTHERAPORT]

🧵 We are celebrating the #InternationalDayOfLight and the incredible potential of light to transform healthcare.

At the #PHOTOTHERAPORT Project, we’re developing innovative therapies that combine light-emitting implants and light-controlled drugs

[PHOTOTHERAPORT @PHOTOTHERAPORT]

⚡ By combining both technologies, we aim to create localized anti-inflammatory and neuroinhibitory treatments that could help reduce: 
→ Chronic pain 
→ Inflammation 
→ Epileptic seizures

[IBEC @IBECBarcelona]

🔬🍻 Science with light at Pint of Science

Luisa Camerin, researcher at #IBEC, will talk about photopharmaceutical. A promising technology for pain, epilepsy & vision disorders.

📍 Cafeteria Casal Sant Adrià | 🕖 7:00 PM
👉 Info & tickets: https://t.co/FM8L5BZm9i

[PHOTOTHERAPORT @PHOTOTHERAPORT]

At the Estonian Embassy in Riga for “Start-up Growth Playbook” (Funding, Investments & Cross-Border Networks).

Rossella Castagna presented #PHOTOTHERAPORT, highlighting #CrossBorderCollaboration & #ShareOfExpertise in EIC Pathfinder. Thanks to Marija Plotniece & the Embassy.

[PHOTOTHERAPORT @PHOTOTHERAPORT]

🔬✨ #PHOTOTHERAPORT at the Science Festival!

Galyna Maleeva (IBEC) will present a microtalk:

💡 “What are photoactivated drugs and how can light help solve health problems?”

📅 18 April · 18:55h
📍 Neurona Stage, Plaça Comercial (Barcelona)

[IBEC @IBECBarcelona]

🗣 Microxerrada – Slam de Ciència

La investigadora Galyna Maleeva participarà amb: “Què són els fotofàrmacs i com la llum pot ajudar a resoldre problemes de salut”, com a part del projecte #PHOTOTHERAPORT

📅 18/04, 18:55h
📍 Escenari Neurona, Plaça Comercial

[PHOTOTHERAPORT @PHOTOTHERAPORT]

🧪 As part of #ShadowDay, LIOS welcomed 48 curious students from 13 Latvian cities! They explored real career paths by shadowing professionals. In biotech, 2 students dove into research & protein structures via #PHOTOTHERAPORT

[PHOTOTHERAPORT @PHOTOTHERAPORT]

🌙 Light-controlled sleep circuits:

#PHOTOTHERAPORT scientists created photorexin, the first photo-reversible ligand for orexin receptors. It modulates wakefulness & locomotion in vivo with nanomolar precision. 🧠💡

https://t.co/0YufCziYeo

[PHOTOTHERAPORT @PHOTOTHERAPORT]

Last week, #Phototheraport researchers came together online for an engaging session on the latest advances in research 🌟

We shared insights, and coordinated efforts to accelerate innovative light-based therapies💡🩺

[PHOTOTHERAPORT @PHOTOTHERAPORT]

✨ For World Epilepsy Day, imagine turning seizures off with light...

EU project #PHOTOTHERAPORT combines tiny implants + photoswitchable drugs to modulate overactive neurons in real time, opening a new frontier in epilepsy therapy💡💜

#EpilepsyAwarenessDay #NeuroInnovation

[PHOTOTHERAPORT @PHOTOTHERAPORT]

⚡ A new light on epilepsy treatment:
#PHOTOTHERAPORT scientists designed photoswitchable carbamazepine analogs for non-invasive control of neuroinhibition.

https://t.co/etgMrrUvyn

[PHOTOTHERAPORT @PHOTOTHERAPORT]

🔦 #PHOTOTHERAPORT scientists created photoswitchable allosteric modulators for M1 receptors, enabling optical GPCR control!

https://t.co/ssp2Te6Rzp

[PHOTOTHERAPORT @PHOTOTHERAPORT]

🔦 Meet azocarnil:

A #PHOTOTHERAPORT breakthrough: light-controlled GABA_A potentiator enabling reversible neuroinhibition in vivo without side effects.

https://t.co/seA0mZ3Uyf

[PHOTOTHERAPORT @PHOTOTHERAPORT]

🧠 From coma to consciousness:

A review with participation of #PHOTOTHERAPORT shows how brain state  identification + neuromodulation (incl. #photopharmacology) could aid recovery in severe brain injuries.

https://t.co/RtRMH7WgWk

[PHOTOTHERAPORT @PHOTOTHERAPORT]

🦴 Osteoarthritis affects more than joints.

A study  with #PHOTOTHERAPORT participation links inflammation to pain, anxiety & cognitive decline, pointing to urinary biomarkers as disease indicators.

https://t.co/zNgLfCSoMn

[PHOTOTHERAPORT @PHOTOTHERAPORT]

🧩 Light-tuned brain rhythms:

Another paper with #PHOTOTHERAPORT participation shows photoswitchable muscarinic drugs can modulate slow waves & block epileptic discharges 🧠💡

https://t.co/TnDSG5H7o8